期刊文献+

Robust reactive oxygen species modulator hitchhiking yeast microcapsules for colitis alleviation by trilogically intestinal microenvironment renovation

原文传递
导出
摘要 Ulcerative colitis(UC)is characterized by chronic inflammatory processes of the intestinal tract of unknown origin.Current treatments lack understanding on how to effectively alleviate oxidative stress,relieve inflammation,as well as modulate gut microbiota for maintaining intestinal homeostasis synchronously.In this study,a novel drug delivery system based on a metal polyphenol network(MPN)was constructed via metal coordination between epigallocatechin gallate(EGCG)and Fe^(3+).Curcumin(Cur),an active polyphenolic compound,with distinguished anti-inflammatory activity was assembled and encapsulated into MPN to generate Cur-MPN.The obtained Cur-MPN could serve as a robust reactive oxygen species modulator by efficiently scavenging superoxide radical(O_(2)•-)as well as hydroxyl radical(⋅OH).By hitchhiking yeast microcapsule(YM),Cur-MPN was then encapsulated into YM to obtain CM@YM.Our findings demonstrated that CM@YM was able to protect Cur-MPN to withstand the harsh gastrointestinal environment and enhance the targeting and retention abilities of the inflamed colon.When administered orally,CM@YM could alleviate DSS-induced colitis with protective and therapeutic effects by scavenging ROS,reducing pro-inflammatory cytokines,and regulating the polarization of macrophages to M1,thus restoring barrier function and maintaining intestinal homeostasis.Importantly,CM@YM also modulated the gut microbiome to a favorable state by improving bacterial diversity and transforming the compositional structure to an anti-inflammatory phenotype as well as increasing the content of short-chain fatty acids(SCFA)(such as acetic acid,propionic acid,and butyric acid).Collectively,with excellent biocompatibility,our findings indicate that synergistically regulating intestinal microenvironment will be a promising approach for UC.
出处 《Bioactive Materials》 SCIE CSCD 2024年第6期203-220,共18页 生物活性材料(英文)
基金 supported by the National Natural Science Foundation of China(Nos.52103183,32360176) the Shaanxi Province Key Research and Development Program(No.2023-YBSF-072) the Natural Science Basic Research Program of Shaanxi(Nos.2021JQ-382,2024JC-YBMS-664) the Fundamental Research Funds for the Central Universities,China(No.xtr052023008) the Innovation Team of Xi’an Medical University(No.2021TD15) the Young Talent Support Plan of Xi’an Jiaotong University,China(No.YX6J001).
  • 相关文献

参考文献2

二级参考文献12

  • 1Silvio Danese,Claudio Fiocchi.Etiopathogenesis of inflammatory bowel diseases[J].World Journal of Gastroenterology,2006,12(30):4807-4812. 被引量:61
  • 2M. Garg,J. S. Lubel,M. P. Sparrow,S. G. Holt,P. R. Gibson.Review article: vitamin D and inflammatory bowel disease – established concepts and future directions[J].Aliment Pharmacol Ther.2012(4)
  • 3DavidBernardo,SaraVallejo‐Díez,Elizabeth R.Mann,Hafid O.Al‐Hassi,BeatrizMartínez‐Abad,EnriqueMontalvillo,Cheng T.Tee,Aravinth U.Murugananthan,HenarNú?ez,Simon T. C.Peake,Ailsa L.Hart,LuisFernández‐Salazar,Jose A.Garrote,EduardoArranz,Stella C.Knight.IL‐6 promotes immune responses in human ulcerative colitis and induces a skin‐homing phenotype in the dendritic cells and Tcells they stimulate[J].Eur J Immunol.2012(5)
  • 4AntonioDi Sabatino,PaoloBiancheri,LauraRovedatti,Thomas T.MacDonald,Gino R.Corazza.New pathogenic paradigms in inflammatory bowel disease[J].Inflamm Bowel Dis.2012(2)
  • 5J.R. Goodhand,F.I.S. Greig,Y. Koodun,A. McDermott,M. Wahed,L. Langmead,D.S. Rampton.Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case‐matched observational study[J].Inflamm Bowel Dis.2011(7)
  • 6Michael H. Shaw,Nobuhiko Kamada,Neil Warner,Yun-Gi Kim,Gabriel Nu?ez.The ever-expanding function of NOD2: autophagy, viral recognition, and T cell activation[J].Trends in Immunology.2011(2)
  • 7Arthur Kaser,Richard S. Blumberg.Autophagy, Microbial Sensing, Endoplasmic Reticulum Stress, and Epithelial Function in Inflammatory Bowel Disease[J].Gastroenterology.2011(6)
  • 8Mark S. Wilson,Thirumalai R. Ramalingam,Aymeric Rivollier,Kevin Shenderov,Margaret M. Mentink–Kane,Satish K. Madala,Allen W. Cheever,David Artis,Brian L. Kelsall,Thomas A. Wynn.Colitis and Intestinal Inflammation in IL10 ?/? Mice Results From IL-13Rα2–Mediated Attenuation of IL-13 Activity[J].Gastroenterology.2011(1)
  • 9Sa’ad Y.Salim,Johan D.S?derholm.Importance of disrupted intestinal barrier in inflammatory bowel diseases[J].Inflamm Bowel Dis.2010(1)
  • 10T.Sugihara,A.Kobori,H.Imaeda,T.Tsujikawa,K.Amagase,K.Takeuchi,Y.Fujiyama,A.Andoh.The increased mucosal mRNA expressions of complement C3 and interleukin‐17 in inflammatory bowel disease[J].Clinical & Experimental Immunology.2010(3)

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部